Acrivon Therapeutics, Inc.

NasdaqGM:ACRV Stock Report

Market Cap: US$203.9m

Acrivon Therapeutics Dividends and Buybacks

Dividend criteria checks 0/6

Acrivon Therapeutics does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-33.0%

Buyback Yield

Total Shareholder Yield-33.0%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

We're Not Very Worried About Acrivon Therapeutics' (NASDAQ:ACRV) Cash Burn Rate

Nov 17
We're Not Very Worried About Acrivon Therapeutics' (NASDAQ:ACRV) Cash Burn Rate

Breaking Down Acrivon: Deep Dive Into Revenue, Profitability, And Prospects

Sep 18

Is Acrivon Therapeutics (NASDAQ:ACRV) In A Good Position To Invest In Growth?

Jul 17
Is Acrivon Therapeutics (NASDAQ:ACRV) In A Good Position To Invest In Growth?

Here's Why We're Not Too Worried About Acrivon Therapeutics' (NASDAQ:ACRV) Cash Burn Situation

Mar 29
Here's Why We're Not Too Worried About Acrivon Therapeutics' (NASDAQ:ACRV) Cash Burn Situation

Acrivon Therapeutics (NASDAQ:ACRV) Is In A Good Position To Deliver On Growth Plans

Oct 05
Acrivon Therapeutics (NASDAQ:ACRV) Is In A Good Position To Deliver On Growth Plans

Acrivon Therapeutics (NASDAQ:ACRV) Is In A Good Position To Deliver On Growth Plans

Jun 22
Acrivon Therapeutics (NASDAQ:ACRV) Is In A Good Position To Deliver On Growth Plans

We Think Acrivon Therapeutics (NASDAQ:ACRV) Can Afford To Drive Business Growth

Feb 22
We Think Acrivon Therapeutics (NASDAQ:ACRV) Can Afford To Drive Business Growth

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if ACRV's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ACRV's dividend payments have been increasing.


Dividend Yield vs Market

Acrivon Therapeutics Dividend Yield vs Market
How does ACRV dividend yield compare to the market?
SegmentDividend Yield
Company (ACRV)n/a
Market Bottom 25% (US)1.3%
Market Top 25% (US)4.2%
Industry Average (Biotechs)2.3%
Analyst forecast (ACRV) (up to 3 years)n/a

Notable Dividend: Unable to evaluate ACRV's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ACRV's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate ACRV's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ACRV has not reported any payouts.


Discover strong dividend paying companies